Concepedia

Erik de Blois

ED

45

Publications

2.2K

Citations

26

H-Index

2004

Active since

Affiliations

Erasmus MC(Current)

Erasmus University Rotterdam

Erasmus MC Cancer Institute

National Centre of Scientific Research "Demokritos"

Joint Research Centre

Erik de Blois is an author at Erasmus MC specializing in pharmacology, medicine, and engineering.

ORCID

Top concepts

Publications per year

2004–2025

45

Publications

45

Radiolabelling DOTA-peptides with 68Ga

Wouter A.P. Breeman, Marion de Jong, Erik de Blois et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2005 · 290 citations

, , +2

Comparison of the Therapeutic Response to Treatment with a <sup>177</sup>Lu-Labeled Somatostatin Receptor Agonist and Antagonist in Preclinical Models

Simone U. Dalm, Julie Nonnekens, Gabriela N. Doeswijk et al. · Journal of Nuclear Medicine · 2015 · 126 citations · Full text

<sup>68</sup>Ga/<sup>177</sup>Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology

Simone U. Dalm, Ingrid L. Bakker, Erik de Blois et al. · Journal of Nuclear Medicine · 2016 · 124 citations · Full text

Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides

Erik de Blois, Ho Sze Chan, Clive Naidoo et al. · Applied Radiation and Isotopes · 2010 · 99 citations

, , +2

Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy

Eline A. M. Ruigrok, Nicole van Vliet, Simone U. Dalm et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 97 citations · Full text

Rows per page

1–5 of 45